(Circulation. 1999;99:1041-1046.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Relationships Among Electrophysiological Findings and Clinical Status, Heart Function, and Extent of DNA Mutation in Myotonic Dystrophy
From Services de Cardiologie et de Biostatistique, Hôpital Cochin, Paris, France (A.L., J.V., Z.O., J.C., S.W., D.D.); Association Cardiologie Val d'Or, St. Cloud, France (A.L.); Laboratoire de Biochimie Génétique, Hôpital Ambroise Paré, Boulogne-Billancourt, France (H.R., C.J.); and Institut de Myologie, Hôpital de la Salpétrière, Paris, France (P.L., B.E., H.M.B.).
Correspondence to Dr Denis Duboc, Service de Cardiologie, Hôpital Cochin 27, Rue du Faubourg St Jacques, 75014 Paris, France. E-mail Alazarus1{at}aol.com
Background—Impulse-conduction abnormalities and arrhythmias are common in myotonic dystrophy (MD). This study was performed to determine whether a correlation exists between electrophysiological (EP) testing data and clinical status, heart function, or size of the DNA abnormality (cytosine-thymine-guanine sequence repeat).
Methods and Results—Eighty-three MD patients underwent invasive EP studies prompted primarily by the presence of asymptomatic conduction abnormalities. AV conduction disturbances were common and mainly distal (HV interval, 66.2±14 ms). AV conduction observed from the surface ECG was generally concordant with endocardial measurements. However, 11 of 20 patients with normal surface ECGs had abnormal subhisian conduction. Atrial arrhythmias were inducible in 41% of cases and correlated with prolongation of the AH interval (P=0.02) and a shorter atrial refractory period (P=0.04). Induction of ventricular arrhythmias (18%) correlated strongly with age (P=0.0003). After adjustment for age, the extent of DNA mutation correlated with the Walton score (P=0.0018) but not with conduction abnormalities or induction of arrhythmias.
Conclusions—Prolongation of the HV interval is the most common conduction abnormality in MD and can be reliably recognized only by invasive EP testing. It raises the issue of prophylactic pacing to limit the incidence of sudden death in MD. Atrial and ventricular arrhythmias are often inducible, although their predictive value remains to be determined. Young age emerged as the most powerful predictor of inducible ventricular tachyarrhythmias. Conversely, we found no relationship between ECG or EP abnormalities recorded during invasive testing and the DNA mutation size or severity of peripheral muscle involvement.
Key Words: myotonic dystrophy • arrhythmia • heart block
This article has been cited by other articles:
 |
|
 |
|
  N. D. Ullrich, M. Fanchaouy, K. Gusev, N. Shirokova, and E. Niggli Hypersensitivity of excitation-contraction coupling in dystrophic cardiomyocytes Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H1992 - H2003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Cudia, P Bernasconi, R Chiodelli, F Mangiola, F Bellocci, A D. Russo, C Angelini, V Romeo, P Melacini, L Politano, et al. Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables J. Neurol. Neurosurg. Psychiatry, July 1, 2009; 80(7): 790 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Russo, M. Pace, F. Bellocci, M. C.E. Hermans, C. G. Faber, Y. M. Pinto, B. Vrtovec, F. Haddad, A. A. Sovari, S. C. Dudley Jr., et al. Sudden Death in Myotonic Dystrophy N. Engl. J. Med., October 9, 2008; 359(15): 1626 - 1629. [Full Text] [PDF]
|
|
|
|
|
|
W. J. Groh, M. R. Groh, C. Saha, J. C. Kincaid, Z. Simmons, E. Ciafaloni, R. Pourmand, R. F. Otten, D. Bhakta, G. V. Nair, et al. Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1 N. Engl. J. Med., June 19, 2008; 358(25): 2688 - 2697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.P. Beynon and S.G. Ray Cardiac involvement in muscular dystrophies QJM, May 1, 2008; 101(5): 337 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bassez, A. Lazarus, I. Desguerre, J. Varin, P. Laforet, H. M. Becane, C. Meune, M. C. Arne-Bes, Z. Ounnoughene, H. Radvanyi, et al. Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1 Neurology, November 23, 2004; 63(10): 1939 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Muntoni Cardiac Complications of Childhood Myopathies J Child Neurol, March 1, 2003; 18(3): 191 - 202. [Abstract] [PDF]
|
|
|
|
 |
|
 G Pelargonio, A D. Russo, T Sanna, G De Martino, and F Bellocci MYOTONIC DYSTROPHY AND THE HEART Heart, December 1, 2002; 88(6): 665 - 670. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lazarus, J. Varin, D. Babuty, F. Anselme, J. Coste, and D. Duboc Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: A multicenter diagnostic pacemaker study J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1645 - 1652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Vignaux, A. Lazarus, J. Varin, J. Coste, P. Carlier, C. Argaud, P. Laforet, S. Weber, P. Legmann, and D. Duboc Right Ventricular MR Abnormalities in Myotonic Dystrophy and Relationship with Intracardiac Electrophysiologic Test Findings: Initial Results Radiology, July 1, 2002; 224(1): 231 - 235. [Abstract] [Full Text]
|
|
|
|
|
|
N R A Clarke, A D Kelion, J Nixon, D Hilton-Jones, and J C Forfar Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy? Heart, October 1, 2001; 86(4): 411 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Antonini, F. Giubilei, A. Mammarella, P. Amicucci, M. Fiorelli, F. Gragnani, S. Morino, V. Ceschin, P. V. Fragola, and M. Gennarelli Natural history of cardiac involvement in myotonic dystrophy: Correlation with CTG repeats Neurology, October 24, 2000; 55(8): 1207 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Merino, R. Peinado, J. A. Sobrino, A. Lazarus, J. Varin, Z. Ounnoughene, H. Radvanyi, C. Junien, J. Coste, P. Laforet, et al. Sudden Death in Myotonic Dystrophy: The Potential Role of Bundle-Branch Reentry • Response Circulation, February 8, 2000; 101 (5): e73 - e73. [Full Text] [PDF]
|
|